Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights a mixed outlook. Despite a record backlog and optimistic guidance on new programs, financial performance has declined, with reduced net income and pretax income. The Q&A reveals uncertainties, such as unclear timelines and specifics on key wins. While optimistic guidance and backlog growth are positive, the financial downturn and lack of clarity on significant contracts balance the sentiment, leading to a neutral prediction.
Revenue $16.9 million for the third fiscal quarter, down from $18.9 million in the same period of the prior fiscal year. The decrease is attributed to strong execution in fiscal 2025, which pulled forward revenue that was originally expected in fiscal 2026.
Revenue from commercial and U.S. government satellite programs $4.2 million (25% of total revenue) compared to $11.2 million (59% of total revenue) in the prior fiscal year. The decline is due to expedited schedules in fiscal 2025.
Revenue from non-space U.S. government and Department of Defense customers $12.5 million compared to $7.4 million in the prior fiscal year, accounting for 74% of total revenue compared to 39% in the prior year. The increase reflects growth in defense-related programs.
Other commercial and industrial revenues $180,000 compared to $367,000 in the prior fiscal year, showing a decline.
Gross margin and gross margin rate Decreased compared to the prior fiscal year due to a change in the mix of high-margin production satellite programs versus lower-margin programs with significant nonrecurring engineering efforts.
Selling, General and Administrative (SG&A) expenses Increased by approximately $213,000, representing 21% of consolidated revenue, up from 18% in the prior year. The increase is due to fluctuations in various expense accounts.
Research and Development (R&D) expenses Increased to approximately $1.8 million (10% of revenue) from $1.4 million (8% of revenue) in the prior fiscal year. The increase is attributed to operational needs supporting ongoing programs.
Operating income $1.3 million compared to $3.5 million in the prior fiscal year. The decrease is due to lower revenue, lower gross margin, and increased SG&A expenses.
Pretax income $1.4 million compared to $3.6 million in the prior fiscal year. The decrease is due to the same factors affecting operating income.
Income tax benefit $127,000 for the current quarter, including a discrete tax benefit of $568,000, compared to $11.8 million in the prior fiscal year, which included a discrete tax benefit of $11.9 million due to the release of the valuation allowance.
Net income $1.6 million ($0.16 per share) compared to $15.4 million ($1.60 per share) in the prior fiscal year. The decrease is due to lower revenue, lower gross margin, and reduced tax benefits.
Backlog Approximately $83 million at the end of January 2026, a new all-time high, compared to $70 million at the end of the previous fiscal year.
Working capital Approximately $32 million at the end of January 2026, with a current ratio of approximately 2.6:1.
New Contracts: Awarded 2 contracts valued at approximately $45 million, one in traditional space satellite programs and one in the new proliferated satellite paradigm.
Quantum Sensing and Alt-PNT: Won new business in magnetometers and quantum sensing, including from the new Colorado facility.
Defense Programs: Increased reliance on traditional defense systems like missile batteries and jet fighters, with growing opportunities in traditional and next-generation defense markets.
Alternative Navigation Systems: Rising demand for Alt-PNT systems due to GPS jamming in conflict zones.
Revenue Performance: Reported $16.9 million in revenue for Q3 FY26, down from $18.9 million YoY but consistent with Q2 FY26.
Backlog Growth: Backlog reached approximately $83 million, a new record, with expectations to surpass $100 million soon.
Market Expansion: Simultaneous growth in traditional and next-generation markets, aiming to become a substantially larger company.
R&D Investment: Increased R&D spending to $1.8 million in Q3 FY26, up from $1.4 million YoY, to support ongoing programs and innovation.
Revenue Decline: The company reported a year-over-year revenue decline for the third fiscal quarter, attributed to pulling forward revenue from fiscal 2026 into fiscal 2025 and delays in anticipated new space bookings.
Gross Margin Decrease: Gross margin and gross margin rate decreased due to a shift in the mix of high-margin production satellite programs to lower-margin programs with significant nonrecurring engineering efforts.
Increased Operating Expenses: Operating expenses increased by approximately $540,000, including $500,000 of nonrecurring expenses, which impacted operating income.
Dependence on Defense Programs: The company’s reliance on defense programs, such as missile systems and interceptors, exposes it to risks related to changes in government defense spending and geopolitical factors.
Supply Chain and Economic Risks: The company faces potential risks from supply chain disruptions and economic uncertainties, particularly in the context of ongoing global conflicts and geopolitical tensions.
Regulatory and Confidentiality Constraints: Customer confidentiality limits the company’s ability to disclose details about significant contracts, which could impact investor confidence and transparency.
R&D Investment Fluctuations: Fluctuations in R&D expenditures, while necessary for innovation, could strain financial resources if not managed effectively.
Revenue Concentration: A significant portion of revenue is derived from U.S. government and Department of Defense contracts, which could pose risks if there are changes in government priorities or budget allocations.
Growth in new markets: The company anticipates growth in new markets such as quantum sensing, proliferated satellites, and alternative position, navigation, and timing (Alt-PNT) programs, in addition to continued growth in its traditional space and defense businesses.
Contract awards: The company expects additional contract awards of similar magnitude to the recently announced $45 million contracts within this calendar year.
Backlog expectations: The company projects its backlog could exceed $100 million in the near future, building on the current record backlog of approximately $83 million.
Defense business growth: The company expects its defense business to grow significantly, driven by increased deployment of missile batteries and traditional defense systems, as well as next-generation defense technologies.
Alternative PNT systems: The company foresees increased demand for Alt-PNT systems, including quantum sensing and magnetometers, due to global GPS jamming issues, with expectations for substantial business growth in this area in the coming years.
Gross margin improvement: The company expects gross margins to improve over time as it adds more business with higher rates of unit production and follow-on business from successful programs.
The selected topic was not discussed during the call.
The earnings call highlights a mixed outlook. Despite a record backlog and optimistic guidance on new programs, financial performance has declined, with reduced net income and pretax income. The Q&A reveals uncertainties, such as unclear timelines and specifics on key wins. While optimistic guidance and backlog growth are positive, the financial downturn and lack of clarity on significant contracts balance the sentiment, leading to a neutral prediction.
The earnings call highlights strong financial health with a 17% increase in backlog and a strong current ratio. Despite a decrease in EPS and lower margins due to program delays, the company expects margin normalization and revenue recovery. The strategic focus on quantum technology and potential in military and space applications is promising. Analysts' concerns were addressed, and the Colorado operations are anticipated to contribute positively soon. Overall, positive financial metrics, strategic growth plans, and optimistic guidance suggest a positive stock price movement.
The earnings call reveals significant concerns: decreased revenue, lower R&D spending, and increased SG&A expenses. Despite a slight backlog increase and share repurchase plans, the company's dependence on government contracts and global timing vulnerabilities add risk. The Q&A section highlights unclear responses regarding key technologies, further dampening sentiment. Overall, the negative financial results and uncertainties outweigh the positive aspects, leading to a negative sentiment.
The earnings call presents strong financial performance with significant increases in net income and margins. The optimistic guidance on government funding and new business opportunities, despite a slight backlog decrease, suggests positive future prospects. The Q&A section reveals cautious optimism in quantum sensing and satellite developments, while management's responses are generally positive. These factors, coupled with a solid working capital position and positive guidance, indicate a likely stock price increase in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.